Peptone Appoints New Leaders to C-Suite
The company announced new hires for its chief scientific officer, chief business officer, and other leadership roles.
Peptone, a biophysics company designing novel therapeutics against IDPs, announced multiple new hires for its leadership team.
In a press release, the company announced that Patrik Foerch, PhD, has been appointed as chief scientific officer. David Lowe, PhD, has also been appointed to the role of senior vice president of protein therapeutics, while Benjamin Owens, PhD, will move to the role of chief business officer from his previous role as chief strategy officer.
Peptone’s CEO, Kamil Tamiola, PhD, said in a press release, “The expansion of Peptone's executive team with deep drug discovery and development expertise comes at an important moment in time for the company and will enable us to capitalize on our proprietary computational and experimental approaches, accelerating the company's internal drug discovery programs and external partnerships. We are thrilled to welcome Patrik and David to the organization and grateful for Benjamin and Andrew's leadership and contributions in this important new phase of the company's development and growth."
Source
(Sept. 28, 2023); Peptone; Peptone Expands Leadership Team with Key Executive Hires; https://www.prnewswire.com/news-releases/peptone-expands-leadership-team-with-key-executive-hires-301941099.html
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
